BIOLASE To Participate In H.C. Wainwright Investor Conference
BIOLASE, the global leader in dental lasers, announced that CEO John Beaver will provide an overview of the company at the H.C.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BIOLASE, the global leader in dental lasers, announced that CEO John Beaver will provide an overview of the company at the H.C. Wainwright Global Life Sciences Investor Conference on March 9-10, 2021. The presentation will highlight recent progress and achievements. Investors can schedule one-on-one meetings with BIOLASE executives. The formal presentation will be available on the company’s investor relations webpage. BIOLASE is known for its innovative laser systems, having sold over 41,200 systems worldwide, enhancing dental care with patented technologies.
Details
News Market Reaction – BIOL
The recorded move for BIOL in the trading session of this news was +5.32%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FOOTHILL RANCH, Calif., Feb. 24, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that John Beaver, President and Chief Executive Officer, will be providing an overview of the Company, as well as recent progress and achievements at the H.C. Wainwright Global Life Sciences Investor Conference, which is being held virtually March 9 - 10, 2021.
The conference will feature virtual one-on-one meetings with the BIOLASE executives and institutional investors are invited to request meeting times at tkehrli@evcgroup.com or through their H.C. Wainwright representative. The formal, pre-recorded, presentation will be available in the investor relations section of BIOLASE's website at www.biolase.com.
About BIOLASE, Inc.
BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.
For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.
View original content to download multimedia:http://www.prnewswire.com/news-releases/biolase-to-participate-in-hc-wainwright-investor-conference-301234380.html
SOURCE BIOLASE, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.